[{"Assets_0_Q3_USD":98886058.0,"CommonStockSharesOutstanding_0_Q3_shares":3683639.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-3863540.0,"NetIncomeLoss_1_Q3_USD":-13387672.0,"NetIncomeLoss_3_Q3_USD":-25392600.0,"StockholdersEquity_0_Q3_USD":-278842379.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":10900000.0,"Ticker":"ARVN","CIK":"1655759","name":"ARVINAS, INC.","OfficialName":"Arvinas Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3525475441.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181114"}]